Compound Summary
药名: | magnolol |
别名: | UPCMLD-DP037:001; UNII-001E35HGVF; 001E35HGVF; TR-031540; FT-0628104; SR-01000758206-3; AN-15430; 2'-Bichavicol; NSC 293099; MLS001048917; STK801955; KS-000009BG; ZINC00001645; [1,1'-Biphenyl]-2,2'-diol, 5,5'-di-2-propenyl-; 5,5'-bis(prop-2-en-1-yl)-[1,1'-biphenyl]-2,2'-diol; HMS3651O18; ZINC1645; PubChem19035; DS-1284; CTK1G9448; ST24029219; NCGC00161609-01; 2-(2-hydroxy-5-prop-2-enyl-phenyl)-4-prop-2-enyl-phenol; 5,5'-Di-2-propenyl-[1,1'-biphenyl]-2,2'-diol; HY-N0163; BN0720; 2-(2-hydroxy-5-prop-2-enylphenyl)-4-prop-2-enylphenol; MFCD00016658; SMP2_000086; SCHEMBL132477; 5,5'-Diallyl-2,2'-dihydroxybiphenyl; (1,1'-Biphenyl)-2,2'-diol, 5,5'-di-2-propenyl-; 3r5n; BC205200; Magnolol, European Pharmacopoeia (EP) Reference Standard; NSC293099; Magnolol, >=95% (HPLC), from plant; ACN-035415; SMR000387108; CM0085; Magnolol; NCGC00161609-02; magnolol ; MCULE-1351244567; AB0016717; VVOAZFWZEDHOOU-UHFFFAOYSA-N; 4-allyl-2-(5-allyl-2-hydroxy-phenyl)phenol; 2-[2-hydroxy-5-(prop-2-en-1-yl)phenyl]-4-(prop-2-en-1-yl)phenol; 5,5'-Diallyl-[1,1'-biphenyl]-2,2'-diol; 2-(2-oxidanyl-5-prop-2-enyl-phenyl)-4-prop-2-enyl-phenol; 528-43-8; 4-allyl-2-(5-allyl-2-hydroxyphenyl)phenol; HMS2269N09; Dehydrodichavicol; AC1Q7B1V; 4CN-0760; D3971; 5,5′-Diallyl-2,2′-biphenyldiol; BBL027818; s2321; 5,5'-Diallylbiphenyl-2,2'-diol; NSC-293099; KB-279770; CHEMBL180920; CCG-208588; AJ-08064; S-2836; 5,5'-Diallyl-2,2'-biphenyldiol; 5,5'-di(prop-2-en-1-yl)biphenyl-2,2'-diol; SR-01000758206; HSDB 7686; DTXSID0044076; AIDS-002239; BR-72952; CHEBI:6643; SC-25620; J10186; 5,5;-Diallyl-[1,1;-biphenyl]-2,2;-diol; M3445_SIGMA; UPCMLD-DP037; 528M438; BDBM78304; I01-2281; O906; Q-100598; AX8016874; LS-44356; AIDS002239; 2,2'-Bichavicol; BG00615874; Kopnolia; AC-931; N1359; SR-01000758206-4; AK-72952; MolPort-002-507-434; BB_NC-1463; Bio-0675; BRD-K26168087-001-01-4; RTR-031540; AKOS005266409; ZB000381; REGID_for_CID_72300; cid_72300; C-16714; C10651; AC1L2HT7; SY016075; CC-30123; CJ-00060; CS-5021 |
分子式: | C18H18O2 |
Smiles: | C([H])([H])=C([H])C([H])([H])c1c([H])c([H])c(O[H])c(c2c([H])c(C([H])([H])C([H])=C([H])[H])c([H])c([H])c2O[H])c1[H] |
成分: | HBIN034250 |
CAS_id: | 528-43-8 |
SymMap_id: | SMIT01500;SMIT02857 |
TCMID_id: | 13381 |
TCMSP_id: | MOL000210 |
PubChem_id: | 72300 |
植物ID | 拉丁名 | 药用植物名 | 药名 | 来源 | 功能与主治 | 使用民族 |
---|
TCMBANKHE006453 | Fructus Momordicae | 罗汉果 | To remove heat, moisten the lung and relax the bowels./Lung heat dry cough, common cold, throat pain, laryngitis, aphonia due to throat pain, intestinal dry and constipation. | |||
TCMBANKHE003858 | Semen Strychni Praeparata | 炙马钱子 | Treatment of protracted arthritis, rheumatoid arthralgia, numbness and paralysis, sequala of poliomyelitis, traumatic injury, boils and sores./Treatment of protracted arthritis, rheumatoid arthralgia, numbness and paralysis, sequala of poliomyelitis, traumatic injury, boils and sores. | |||
TCMBANKHE004198 | Magnolia biondii [Syn. Magnolia fargesii] | 望春玉兰 | See Magnolia liliflora./See Magnolia liliflora. | |||
TCMBANKHE004608 | Magnolia grandiflora | 荷花玉兰 | To dispel wind and dissipate cold, move qi and relieve pain./Externally contracted wind-cold, headache and nasal congestion, distending pain in stomach duct, vomiting and diarrhea, hypertension, tuberculosis. | |||
TCMBANKHE009013 | Cortex Illicii | 地枫皮 | To relieve rheumatic conditions, and to promote the flow of qi and relieve pain./Pain in joints due to rheumatalgia, taxation damage in lumbar muscle, centipede bite. | |||
TCMBANKHE004771 | Magnolia obovata | 日本厚朴 | ||||
TCMBANKHE005168 | 辛夷 | Wind-cold common cold, headache, nasal congestion and runny nose, nasitis, nasosinusitis. | ||||
TCMBANKHE005338 | Sassafras randainense | 台湾檫木 | ||||
TCMBANKHE007292 | 藁本 | Headache due to externally contracted wind-cold, vertex headache, pain in tooth and cheek, migraine, wind-cold-damp impediment, pain in limbs. | ||||
TCMBANKHE005228/YEM-235 | Cortex Magnoliae officilis;Magnolia officinalis|Magnolia officinalis Rehd.et Wils. | 厚朴 | 厚朴 | 云南民族药物志:第二卷 | To eliminate damp and relieve distension;To dry damp and disperse phlegm, precipitate qi and eliminate fullness, lower blood pressure./1. Broad-spectrum antibacterial.2. Magnocurarine, one of the active components, can relaxstriated muscles.3. Its decoction stimulates the smooth muscles of intestines and bronchii in rabbits in vitro.4. Magnocuraine may also lower blood pressure and accelerate heart rate.5.Amebic dysentery, vomiting and diarrhea, food accumulation and qi stagnation, abdominal distention and constipation, phlegm-rheum cough asthma. | 彝族 |
TCMBANKHE007340/YEM-235 | Flos Magnoliae Offcinalis|Magnolia officinalis Rehd.et Wils. | 厚朴花|厚朴 | 厚朴 | 云南民族药物志:第二卷 | Treatment of feeling of stuffiness and distension in the chest and epigastrium with loss of appetite./Treatment of feeling of stuffiness and distension in the chest and epigastrium with loss of appetite. | 彝族 |
TCMBANKHE002025/YEM-235 | Magnoliae Officinalis Praeparata|Magnolia officinalis Rehd.et Wils. | 炙厚朴|厚朴 | 厚朴 | 云南民族药物志:第二卷 | Treatment of accumulation of damp in the spleen and the stomach marked by epigastric strffiness, vomiting and diarrhea, abdominal distension and constipation due to retention of undigested food, cough and dyspnea caused by retanied damp./1. Broad-spectrum antibacterial.2. Magnocurarine, one of the active components, can relaxstriated muscles.3. Its decoction stimulates the smooth muscles of intestines and bronchii in rabbits in vitro.4. Magnocuraine may also lower blood pressure and accelerate heart rate. | 彝族 |
TCMBANKHE004240/YEM-586 | Magnolia rostrata|Magnolia rostrata W.W.Sm. | 大叶厚朴|长喙厚朴 | 贡山厚朴 | 云南民族药物志:第三卷 | To warm center and transform damp, move qi and disperse accumulation./Distention fullness and sudden pain in chest and abdomen, food accumulation and qi stagnation, vomiting, diarrhea, cough with profuse phlegm. | 傈僳族 |
疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
---|
TCMBANKDI000047 | Neoplasm Metastasis | phenotype | Pathological Conditions, Signs and Symptoms; Neoplasms | 21757288 |
TCMBANKDI000085 | Inflammation | phenotype | Pathological Conditions, Signs and Symptoms | 30597199 |
TCMBANKDI000088 | Lung Neoplasms | group | Neoplasms; Respiratory Tract Diseases | 27268146 |
TCMBANKDI003733 | Cerebral Hemorrhage | phenotype | Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases | 30597199 |
TCMBANKDI015773 | Brain Edema | phenotype | Nervous System Diseases | 30597199 |
TCMBANKDI025605 | Seizures | phenotype | Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 21518336 |
TCMBANKDI026887 | ovarian neoplasm | disease | Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 21757288 |
TCMBANKDI031985 | Brain Ischemia | disease | Nervous System Diseases; Cardiovascular Diseases | 30597199 |
靶点ID | 基因名 | 基因别名 | 描述 |
---|
TCMBANKGE000162 | MMP13 | CLG3; MANDP1; MDST; MMP-13 | matrix metallopeptidase 13 |
TCMBANKGE000181 | PIM1 | PIM | Pim-1 proto-oncogene, serine/threonine kinase |
TCMBANKGE000201 | ESR1 | ER; ESR; ESRA; ESTRR; Era; NR3A1 | estrogen receptor 1 |
TCMBANKGE000205 | NOS2 | HEP-NOS; INOS; NOS; NOS2A | nitric oxide synthase 2 |
TCMBANKGE000248 | MMP10 | SL-2; STMY2 | matrix metallopeptidase 10 |
TCMBANKGE000286 | GSK3B | - | glycogen synthase kinase 3 beta |
TCMBANKGE000309 | SCN5A | CDCD2; CMD1E; CMPD2; HB1; HB2; HBBD; HH1; ICCD; IVF; LQT3; Nav1.5; PFHB1; SSS1; VF1 | sodium voltage-gated channel alpha subunit 5 |
TCMBANKGE000360 | CCNA2 | CCN1; CCNA | cyclin A2 |
TCMBANKGE000389 | MMP3 | CHDS6; MMP-3; SL-1; STMY; STMY1; STR1 | matrix metallopeptidase 3 |
TCMBANKGE000478 | CHEK1 | CHK1 | checkpoint kinase 1 |
TCMBANKGE000514 | CNR1 | CANN6; CB-R; CB1; CB1A; CB1K5; CB1R; CNR | cannabinoid receptor 1 |
TCMBANKGE000633 | ADRB2 | ADRB2R; ADRBR; B2AR; BAR; BETA2AR | adrenoceptor beta 2 |
TCMBANKGE000701 | ESR2 | ER-BETA; ESR-BETA; ESRB; ESTRB; Erb; NR3A2; ODG8 | estrogen receptor 2 |
TCMBANKGE000753 | CNR2 | CB-2; CB2; CX5 | cannabinoid receptor 2 |
TCMBANKGE000787 | VCAM1 | CD106; INCAM-100 | vascular cell adhesion molecule 1 |
TCMBANKGE000813 | DPP4 | ADABP; ADCP2; CD26; DPPIV; TP103 | dipeptidyl peptidase 4 |
TCMBANKGE000903 | PTGS1 | COX1; COX3; PCOX1; PES-1; PGG/HS; PGHS-1; PGHS1; PHS1; PTGHS | prostaglandin-endoperoxide synthase 1 |
TCMBANKGE000935 | S100B | NEF; S100; S100-B; S100beta | S100 calcium binding protein B |
TCMBANKGE000938 | CDK2 | CDKN2; p33(CDK2) | cyclin dependent kinase 2 |
TCMBANKGE000986 | ERBB2 | CD340; HER-2; HER-2/neu; HER2; MLN 19; NEU; NGL; TKR1 | erb-b2 receptor tyrosine kinase 2 |
TCMBANKGE001045 | CCND1 | BCL1; D11S287E; PRAD1; U21B31 | cyclin D1 |
TCMBANKGE001073 | PTGS2 | COX-2; COX2; GRIPGHS; PGG/HS; PGHS-2; PHS-2; hCox-2 | prostaglandin-endoperoxide synthase 2 |
TCMBANKGE001114 | IL6 | BSF-2; BSF2; CDF; HGF; HSF; IFN-beta-2; IFNB2; IL-6 | interleukin 6 |
TCMBANKGE001118 | MMP9 | CLG4B; GELB; MANDP2; MMP-9 | matrix metallopeptidase 9 |
TCMBANKGE001156 | CASP3 | CPP32; CPP32B; SCA-1 | caspase 3 |
TCMBANKGE001185 | PPARG | CIMT1; GLM1; NR1C3; PPARG1; PPARG2; PPARG5; PPARgamma | peroxisome proliferator activated receptor gamma |
TCMBANKGE001197 | FOS | AP-1; C-FOS; p55 | Fos proto-oncogene, AP-1 transcription factor subunit |
TCMBANKGE001202 | MAPK14 | CSBP; CSBP1; CSBP2; CSPB1; EXIP; Mxi2; PRKM14; PRKM15; RK; SAPK2A; p38; p38ALPHA | mitogen-activated protein kinase 14 |
TCMBANKGE001697 | MMP1 | CLG; CLGN | matrix metallopeptidase 1 |
TCMBANKGE001755 | MAOB | - | monoamine oxidase B |
TCMBANKGE001943 | ADRA1D | ADRA1; ADRA1A; ADRA1R; ALPHA1; DAR; dJ779E11.2 | adrenoceptor alpha 1D |
TCMBANKGE003625 | SLC6A4 | 5-HTT; 5-HTTLPR; 5HTT; HTT; OCD1; SERT; SERT1; hSERT | solute carrier family 6 member 4 |
TCMBANKGE004266 | AR | AIS; AR8; DHTR; HUMARA; HYSP1; KD; NR3C4; SBMA; SMAX1; TFM | androgen receptor |
TCMBANKGE005535 | CHRM1 | HM1; M1; M1R | cholinergic receptor muscarinic 1 |
TCMBANKGE006943 | CHRM3 | EGBRS; HM3; PBS | cholinergic receptor muscarinic 3 |
TCMBANKGE008048 | SLC5A7 | CHT; CHT1; CMS20; HMN7A | solute carrier family 5 member 7 |
TCMBANKGE008397 | MMP27 | MMP-27 | matrix metallopeptidase 27 |
TCMBANKGE008921 | RXRA | NR2B1 | retinoid X receptor alpha |
TCMBANKGE009256 | SLC6A2 | NAT1; NET; NET1; SLC6A5 | solute carrier family 6 member 2 |
TCMBANKGE009373 | MMP8 | CLG1; HNC; MMP-8; PMNL-CL | matrix metallopeptidase 8 |
TCMBANKGE009758 | PDE3A | CGI-PDE; CGI-PDE A; CGI-PDE-A; HTNB | phosphodiesterase 3A |
TCMBANKGE011079 | PRSS1 | TRP1; TRY1; TRY4; TRYP1 | serine protease 1 |
TCMBANKGE012155 | SLC6A3 | DAT; DAT1; PKDYS; PKDYS1 | solute carrier family 6 member 3 |
TCMBANKGE014050 | GABRA1 | ECA4; EIEE19; EJM; EJM5 | gamma-aminobutyric acid type A receptor subunit alpha1 |